UNH · NYSE · Health insurance
Health insurance and Optum care services.
In the last 90 days, no insider of UnitedHealth reported an open-market purchase and 2 open-market sales worth about $661K. Members of Congress disclosed 8 trades in its stock. The latest 13F reports cover the quarter ending Jun 30, 2026. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$378.58
Last 12 months
+5.1%
Market value
$340B
S&P 500 +15.8% over the same dates. Prices adjusted for splits and dividends.
Bets against the stock: 13.2M shares sold short (1.5% of shares outstanding), −13.6% vs the previous count, 2.5 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
UnitedHealth: 3 funds cut or exited a position in the latest 13F filings and 1 member of Congress disclosed sales. 2 of 3 kinds of disclosure lean the same way. This counts filings; it does not say why, or what happens next. How well this has worked
Revenue
$112B
+0.4% vs the same quarter a year earlier
Free cash flow, last 12 months
$23.6B
This quarter $10.3B, a year earlier $6.3B
Net debt
$44.7B
Debt $73.3B, cash $28.6B, at Jun 30, 2026
Backlog
$10.7B
Work contracted but not yet delivered, as the company reports it
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 16, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
2 sales
$661K sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$448B
+11.8% vs the year before
Net income, fiscal 2025
$12.1B
As reported in the annual filing
Shares outstanding
898M
As of Jul 31, 2026
In fiscal 2025 the company spent $5.54B buying back its own shares and $7.92B on dividends. Cash actually paid, from its cash-flow statement.
Kevin Hern soldRepublican, Representative, OK district 1Sits on House Ways and Means, Health3 different filers disclosed UNH within 90 days. Disclosed 15 days after the transaction; reported as an official range, not an exact amount.
Stock since the trade −3.0% · S&P 500 +1.2% · to Oct 5
The boss of UnitedHealth sold $456K of UnitedHealth shares. Nobody planned it ahead of time.
Officer plans to sell ~$456K of UnitedHealth
Planned, from pay
John Boozman boughtRepublican, Senator, AR18 different filers disclosed UNH within 90 days. Disclosed 491 days after the transaction; reported as an official range, not an exact amount.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Vanguard Capital Management
Schedule 13G: passive · filed Apr 30, 2026 · 68.1M shares
STATE STREET CORPORATION
Schedule 13G: passive · filed Aug 7, 2026 · 45.7M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
A securities lawsuit naming the company as a defendant was filed on Mar 20, 2026 in the U.S. District Court, District of Columbia. A filing is an allegation, not a finding.
FONDS DES MISSIONS v. UNITEDHEALTH GROUP INCORPORATED, 1:26-cv-00970A securities lawsuit naming the company as a defendant was filed on May 14, 2024 in the U.S. District Court, D. Minnesota. A filing is an allegation, not a finding.
California Public Employees' Retirement System v. UnitedHealth Group Inc., 0:24-cv-01743Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). 1 case in that period is closed and not listed. Coverage of court records is not complete, and shareholder derivative suits are not included.
Last 12 months, adjusted daily closes
Adjusted close went from $358.77 on Oct 6, 2025 to $378.58 on Oct 5, 2026 (+5.5%). Disclosed activity in the last 12 months: 0 insider purchases, 3 insider sales, 13 Congress purchases, 13 Congress sales, 1 fund report of opening or adding and 3 fund reports of trimming or selling out (13F, quarter-end snapshots).
Short sale volume: 41.6% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 35.8%. FINRA daily files, to Oct 5, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
